Commitment COM-228
Post-approval commitment for MHRA-2022-0028. Category: REMS. Priority: low.
Commitment ID
COM-228
Application
Authority
Medicines and Healthcare products Regulatory Agency
Category
REMS
Priority
low
Status
Blocked
Due Date
2025-09-15
Completed At
—
Owner
James O'Brien
Created
2023-02-11
Description
Complete Phase IV post-marketing observational study (n=500)
Evidence (0)
No evidence documents attached. Upload evidence to mark this commitment as complete.